About Zenas BioPharma
Zenas BioPharma is a company based in Fort Myers (United States) founded in 2020.. Zenas BioPharma has raised $318.15 million across 2 funding rounds from investors including Xencor, Norwest Venture Partners and Fairmont Hotels & Resorts. The company has 130 employees as of December 31, 2024. Zenas BioPharma offers products and services including Obexelimab. Zenas BioPharma operates in a competitive market with competitors including AllStripes, Prime Global, CTI Clinical Trial, Agility Clinical and Neurenati, among others.
- Headquarter Fort Myers, United States
- Employees 130 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Zenas Biopharma, Inc.
-
Annual Revenue
$5 M-90as on Dec 31, 2024
-
Net Profit
$-156.99 M-322.87as on Dec 31, 2024
-
EBITDA
$-163.75 M-505.72as on Dec 31, 2024
-
Total Equity Funding
$318.15 M (USD)
in 2 rounds
-
Latest Funding Round
$200.15 M (USD), Series C
May 03, 2024
-
Investors
Xencor
& 18 more
-
Employee Count
130
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Zenas BioPharma
Zenas BioPharma is a publicly listed company on the NASDAQ with ticker symbol ZBIO in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Zenas BioPharma
Zenas BioPharma offers a comprehensive portfolio of products and services, including Obexelimab. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Bifunctional antibody targeting B cell activity in autoimmune diseases.
Unlock access to complete
Unlock access to complete
Leadership Team
21 people
Software Development Team
7 people
Human Resources and Administration
5 people
Finance and Accounting
4 people
Operations Team
3 people
Legal and Compliance
2 people
Product Management Team
2 people
Sales and Marketing
1 people
Unlock access to complete
Funding Insights of Zenas BioPharma
Zenas BioPharma has successfully raised a total of $318.15M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $200.15 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series C — $200.1M
-
First Round
First Round
(02 Nov 2022)
- Investors Count 19
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2024 | Amount | Series C - Zenas BioPharma | Valuation | SR One , New Enterprise Associates | |
| Nov, 2022 | Amount | Series B - Zenas BioPharma | Valuation | Enavate Sciences |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Zenas BioPharma
Zenas BioPharma has secured backing from 19 investors, including venture fund and institutional investors. Prominent investors backing the company include Xencor, Norwest Venture Partners and Fairmont Hotels & Resorts. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A biotechnology venture capital firm investing in innovative science.
|
Founded Year | Domain | Location | |
|
Venture capital investments are offered to startups by NEA.
|
Founded Year | Domain | Location | |
|
Venture capital and growth equity firm providing investments and resources to entrepreneurs in various sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Zenas BioPharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Zenas BioPharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Zenas Biopharma Comparisons
Competitors of Zenas BioPharma
Zenas BioPharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AllStripes, Prime Global, CTI Clinical Trial, Agility Clinical and Neurenati, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of information to patients and communities with the medical data for rare diseases
|
|
| domain | founded_year | HQ Location |
Medical communication solutions are provided for healthcare professionals.
|
|
| domain | founded_year | HQ Location |
Provides clinical trials, consulting, and regulatory services in healthcare sectors.
|
|
| domain | founded_year | HQ Location |
CRO with a special focus on orphan drug development
|
|
| domain | founded_year | HQ Location |
Biotech company focused on developing therapies for rare diseases, with a current focus on Hirschsprung disease
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Zenas Biopharma
Frequently Asked Questions about Zenas BioPharma
When was Zenas BioPharma founded?
Zenas BioPharma was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Where is Zenas BioPharma located?
Zenas BioPharma is headquartered in Fort Myers, United States. It is registered at Fort Myers, Florida, United States.
Is Zenas BioPharma a funded company?
Zenas BioPharma is a funded company, having raised a total of $318.15M across 2 funding rounds to date. The company's 1st funding round was a Series B of $118M, raised on Nov 02, 2022.
How many employees does Zenas BioPharma have?
As of Dec 31, 2024, the latest employee count at Zenas BioPharma is 130.
What is the annual revenue of Zenas BioPharma?
Annual revenue of Zenas BioPharma is $5M as on Dec 31, 2024.
What does Zenas BioPharma do?
Zenas BioPharma was founded in 2020 and is headquartered in Fort Myers, United States. Clinical development services are offered by the company within the biopharmaceutical sector, with a focus on autoimmune and rare diseases. Operations encompass therapeutic advancements and support for drug pipelines, targeting unmet medical needs in these areas. The companys domain, zenasbio.com, facilitates information on its activities.
Who are the top competitors of Zenas BioPharma?
Zenas BioPharma's top competitors include AllStripes, Prime Global and Agility Clinical.
What products or services does Zenas BioPharma offer?
Zenas BioPharma offers Obexelimab.
Is Zenas BioPharma publicly traded?
Yes, Zenas BioPharma is publicly traded on NASDAQ under the ticker symbol ZBIO.
Who are Zenas BioPharma's investors?
Zenas BioPharma has 19 investors. Key investors include Xencor, Norwest Venture Partners, Fairmont Hotels & Resorts, Perceptive Advisors, and Enavate Sciences.
What is Zenas BioPharma's ticker symbol?
The ticker symbol of Zenas BioPharma is ZBIO on NASDAQ.